IART compared with ENOV: revenue, margins and what each company keeps, and the suppliers and customers both name

IARTIntegra Lifesciences Holdings Corp

Mkt capRevenueRevenue

ENOVEnovis Corp

Mkt capRevenueRevenue

Compare

IARTIntegra Lifesciences Holdings Corp

ENOVEnovis Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IART

1 of 2at or beyond implied

Reportimpliedrealized× implied

Oct 21 '26—▼−11.18%—

Q3 FY26—▼−21.19%—

Q2 FY26±10.9%▼−16.55%×1.52

May 5 '26±27.0%▲+24.13%×0.89

ENOV

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±14.4%▲+17.20%×1.19

Q2 FY26±11.8%▼−12.82%×1.08

= impliedIART realized, solidENOV realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

Q1 FY26

±6.8%

▲+9.66%

×1.43

Feb 26 '26±12.3%▲+13.89%×1.13

IARTIntegra Lifesciences Holdings Corp

13.40▼−5.09%· post 13.40

Mkt cap$1.0BRevenue$411MQ3 FY26Revenue$1.6BFY25

ENOVEnovis Corp

27.14▼−5.17%· post 27.10

ClosedNov 6 '26

Mkt cap$1.6BRevenue$559MQ3 FY26Revenue$2.2BFY25

Compare

ClosedNov 6 '26

IARTIntegra Lifesciences Holdings Corp

ENOVEnovis Corp

13.40▼−5.09%post 13.40

Price

27.14▼−5.17%post 27.10

$1.0B

Mkt cap

$1.6B

Q3 FY26$411M

Revenue

$559MQ3 FY26

FY25$1.6B

Revenue

$2.2BFY25

IART13.40▼−5.09%vsENOV27.14▼−5.17%ClosedNov 6 '26